Literature DB >> 19144244

Light microscopy study of cisplatin-induced ototoxicity in rats.

M R de Freitas1, G A de Castro Brito, J V de Carvalho, R M Gomes, M J Barreto Martins, R de Albuquerque Ribeiro.   

Abstract

BACKGROUND: Although most studies on animal ototoxicity employ scanning electron microscopy, all cochlear structures may be identified with light microscopy. This paper describes a simple method of histological assessment of cisplatin-induced ototoxicity in rats, and relates morphological changes to functional changes in hearing detected by distortion product evoked otoacoustic emissions.
MATERIALS AND METHODS: Male Wistar rats were injected with 8 mg/kg/day cisplatin, or with an equivalent volume of saline solution, for three consecutive days. They underwent distortion product evoked otoacoustic emission testing at baseline and at 24 or 48 hours after the last administration. At the end of the experiment, the animals were sacrificed and their cochleae were retrieved and prepared for haematoxylin and eosin staining.
RESULTS: A four-point scoring system was used to grade injury to the external ciliated cells, as indicated by the number of cells absent from the basal turn of the cochlear duct. A four-point scoring system was also used to grade stria vascularis injury, as indicated by the degree of shrinkage of the intermediate cells. Scores were significantly higher in groups treated with cisplatin compared with controls. Morphological changes were confirmed by decreased distortion product evoked otoacoustic emission amplitudes in animals treated with cisplatin.
CONCLUSION: This method is simple to perform with routine histology equipment and is appropriate for the study of acute, cisplatin-induced ototoxicity in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144244     DOI: 10.1017/S0022215109004319

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  8 in total

1.  Effects of ozone (O3) therapy on cisplatin-induced ototoxicity in rats.

Authors:  Hasan Emre Koçak; Ümit Taşkın; Salih Aydın; Mehmet Faruk Oktay; Serdar Altınay; Duygu Sultan Çelik; Kadir Yücebaş; Bengül Altaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-24       Impact factor: 2.503

2.  Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract.

Authors:  Zahide Mine Yazici; Aysenur Meric; Ahmet Midi; Yasar Volkan Arınc; Volkan Kahya; Gunter Hafız
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-27       Impact factor: 2.503

3.  The Protective Effect of Nigella sativa Oil against Experimentally Induced Cisplatin Ototoxicity: An Animal Study.

Authors:  Numan Kökten; Oğuz Kadir Eğilmez; Murat Erinç; A Işın Doğan Ekici; Serkan Şerifler; Erdem Yeşilada; Mahmut Tayyar Kalcıoğlu
Journal:  J Int Adv Otol       Date:  2020-12       Impact factor: 1.017

4.  The effects of lycopene on cisplatin-induced ototoxicity.

Authors:  Mahmut Ozkırış; Zeliha Kapusuz; Seyhan Karaçavuş; Levent Saydam
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-29       Impact factor: 2.503

5.  Protective role of bilberry extract against Cisplatin induced ototoxicity in rats.

Authors:  Zeliha Kapusuz; Mahmut Ozkırış; Mehtap Kala; Levent Saydam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-20

6.  Protective Effect of Carvacrol against Paclitaxel-Induced Ototoxicity in Rat Model.

Authors:  Fatma Atalay; Arzu Tatar; Büşra Dincer; Betül Gündoğdu; Sinan Köyceğiz
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-12-01

7.  Wnt Signaling Protects against Paclitaxel-Induced Spiral Ganglion Neuron Damage in the Mouse Cochlea In Vitro.

Authors:  Xue Wang; Yuechen Han; Man Wang; Chuan Bo; Zhenbiao Zhang; Lei Xu; Wenwen Liu; Haibo Wang
Journal:  Biomed Res Int       Date:  2019-10-07       Impact factor: 3.411

Review 8.  Blood Prestin Levels in Normal Hearing and in Sensorineural Hearing Loss: A Scoping Review.

Authors:  Eleftheria Iliadou; Dimitrios Kikidis; Konstantinos Pastiadis; Christopher J Plack; Athanasios Bibas
Journal:  Ear Hear       Date:  2021 Sep/Oct       Impact factor: 3.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.